Article

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional Analysis

2022-12-07

Abstract excerpt

Background Neutralising antibodies (nAbs) play a critical role in the protection against severe COVID-19. In the era of vaccine boosters and repeated SARS-CoV-2 outbreaks, identifying individuals at risk represents a public health priority. We aimed to evaluate nAb following SARS-CoV-2 vaccination and/or infection in the general population.<br><br>Methods Relying on the Monaco COVID Public Health Programme, we eva...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0cc80bf7-ff10-5959-85b6-c0cd08939864
DOI: 10.2139/ssrn.4233128

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisDOI 10.2139/ssrn.4233128Read

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individualsSemantic proximity Read

SARS-CoV-2 Infection, Vaccination and Antibody Response Trajectories in Adults: A Cohort Study in CataloniaSemantic proximity Read

Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic reviewSemantic proximity Read

Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD studySemantic proximity Read

Long-term neutralizing antibody dynamics against SARS-CoV-2 in symptomatic and asymptomatic infections: a systematic review and meta-analysisSemantic proximity Read

Nationwide SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era, 2021-2022: an Ongoing Prospective Cohort StudySemantic proximity Read

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsSemantic proximity Read

Neutralising antibodies predict protection from severe COVID-19Semantic proximity Read

Demographic and Clinical Factors Associated With Anti–SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine DosesSemantic proximity Read

Impact of SARS-CoV-2 exposure history on antibody kinetics and correlates of protection in The GambiaSemantic proximity Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read

Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity Read